Диссертация (1154715), страница 23
Текст из файла (страница 23)
Broide // Am J Physiol Lung Cell Mol Physiol. — 2009. — Vol.296 (2). P. 210-219.141. Lin, C.C. Pulmonary function changes and increased Th-2 cytokine expressionand nuclear factor kB activation in the lung after sensitization and allergen challenge inbrown Norway rats / C.C. Lin, C.Y. Lin, H.Y. Ma // Immunol. Lett. — 2000. — Vol. 73(1). — P. 57-64.142. Lin, C.H. Childhood type 1 diabetes may increase the risk of atopic dermatitis /C.H. Lin, C.C. Wei, C.L.
Lin, W.C. Lin, C.H. Kao // Br J Dermatol. — 2016. — Vol.174 (1). — P. 88-94.143. Ljubić, S. Reduction of diffusion capacity for carbon monoxide in diabeticpatients / S. Ljubić, Z. Metelko, N. Car, G. Roglić, Z. Drazić. // Chest. — 1998. — Vol.114 (4). — P. 1033-1035.144. Locksley, R.M. Asthma and allergic inflammation / R.M. Locksley // Cell. —2010. — Vol. 140 (6). — P. 777-783.145.
Luijk, B. Gradual increase in priming of human eosinophils during extravasationfrom peripheral blood to the airways in response to allergen challenge / B. Luijk, C.Lindemans, D. Kanters, R. van der Heijde, P. Bertics, J.W. Lammers, M.E. Bates, L.Koenderman // J Allergy Clin Immunol. — 2005. — Vol. 115 (5). — P. 997-1003.146. Mallola, J., The International Study of Asthma and Allergies in Childhood(ISAAC) Phase Three: A global synthesis / J. Mallola, J. Craneb, E.
von Mutiusc, J.Odhiambod, U. Keile, A. Stewartf // Allergol Immunopathol (Madr.). — 2013. — Vol.41(2). — P. 73-85.147. Mandrup-Poulsen, T. The role of interleukin-1 in the pathogenesis of IDDM / T.Mandrup-Poulsen // Diabetologia. — 1996. — Vol. 39 (9). — P.
1005-1029.148. Martinez, F.D. Gene–environment interactions in asthma: with apologies toWilliam of Ockham / F.D. Martinez // Proc Am Thorac Soc. — 2007. — Vol. 4 (1). —P. 26-31.150149. Mathis, D. Back to Central Tolerance / D. Mathis, C.
Benoist // Immunity. —2004. — Vol. 20 (5). — P. 509-516.150. Matsui, S. A model for CD8+ CTL tumor immunosurveillance and regulation oftumor escape by CD4 T cells through an effect on quality of CTL / S. Matsui, J.D.Ahlers, A.O. Vortmeyer, M. Terabe, T. Tsukui, D.P. Carbone, L.A. Liotta, J.A.Berzofsky // J. Immunol. — 1999. — Vol. 163 (1).
— P. 184-193.151. Mattila, P.S. Predisposition to atopic symptoms to inhaled antigens may protectfrom childhood type 1 diabetes / P.S. Mattila, J. Tarkkanen, H. Saxen, J. Pitkäniemi, M.Karvonen, J. Tuomilehto // Diabetes Care. — 2002. — Vol. 25 (5). — P.
865-868.152. Meerwaldt, R. A lower prevalence of atopy symptoms in children with type 1diabetes mellitus / R. Meerwaldt, R.J. Odink, R. Landaeta, F. Aarts, B. Brunekreef, J.Gerritsen, W.M. Van Aalderen, M.O. Hoekstra // Clin Exp Allergy. — 2002. — Vol.32. — P. 254-255.153. Memon, A. Association between atopic disorders and childhood type 1 diabetes:a population-based case control study in the middle east / A. Memon, S.
Polack, M. AlKhawari, M. Qabazard, A. Al-Adsani, M. Abdul-Rasoul, R. Gulati, A. Shaltout, A.Suresh // J Epidemiol Community Health. — 2014. — Vol. 68 (1). — P. 51.154. Meurer, J.R. Asthma severity among children hospitalized in 1990 and 1995 /J.R. Meurer, V. George, S. Subichin, J.
Yauck, P. Layde // Arch Pediatr Adolesc Med.— 2000. — Vol. 154 (2). — P. 143-149.155. Miller, M.R. Standardisation of spirometry / M.R. Miller, J. Hankinson, V.Brusasco, F. Burgos, et al. // Eur Respir J. — 2005. — Vol. 26 (2). — P. 319-338.156. Moher, D. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement / D.
Moher, A. Liberati, J. Tetzlaff, D.G. Altman // Ann InternMed. — 2009. — Vol. 151 (4). — P. 264-269.157. Muse, E.D. Role of resistin in diet-induced hepatic insulin resistance / E.D. Muse,S. Obici, S. Bhanot, B.P. Monia, R.A. McKay, M.W. Rajala, P.E. Scherer, L. Rossetti //J Clin Invest. — 2004. — Vol. 114 (2). — P. 232-239.151158. Nafstad, P.
Risk of childhood asthma and allergic rhinitis in relation to pregnancycomplications / P. Nafstad, P. Magnus, J.J. Jaakkola // J Allergy Clin Immunol. —2000. — Vol. 106 (5). — P. 867-873.159. Nakayama, M. Prime role for an insulin epitope in the development of type 1diabetes in NOD mice / M. Nakayama, N. Abiru, H. Moriyama, N. Babaya, E. Liu, D.Miao, L.
Yu, D.R.Wegmann, J.C. Hutton, J.F. Elliott, G.S. Eisenbarth // Nature. —2005. — Vol. 435 (7039). — P. 220-223.160. Nicolai, T. Puberty and prognosis of asthma and bronchial hyper-reactivity / T.Nicolai, S. Illi, J. Tenbörg, W. Kiess, E. von Mutius / Pediatr Allergy Immunol. —2001. — Vol. 12 (3). — P. 142-148.161. Obesity. Preventing and managing the global epidemic: report of a WHOconsultation of obesity [Электронный ресурс].
— Geneva, Switzerland: WHO, 1997.—Режимдоступа:http://apps.who.int/iris/bitstream/10665/63854/1/WHO_NUT_NCD_98.1_%28p1158%29.pdf.162. O'Gorman, T.W. Using Kendall's tau b correlations to improve variable selectionmethods in case-control studies / T.W. O'Gorman, R.F. Woolson // Biometrics. — 1995.— Vol. 51 (4). — P.
1451-1460.163. Okada, H. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: anupdate / H. Okada, C. Kuhn, H. Feillet, J.F. Bach // Clin Exp Immunol. — 2010. —Vol. 160 (1). — P. 1-9.164. Olesen, A.B. Associationbetween atopic dermatitis and insulin-dependentdiabetes mellitus: a case-control study / A.B. Olesen, S. Juul, N. Birkebaek, K.Thestrup-Pedersen // Lancet.
2001. — Vol. 357 (9270). — P.1749-1752.165. Olsen, P.C. Two for one: cyclic AMP mediates the anti-inflammatory and antispasmodic properties of the non-anesthetic lidocaine analog JMF2-1 / P.C. Olsen, L.P.Coelho, J.C. da Costa, R.S. Cordeiro, P.M. Silva, M.A. Martins // Eur J Pharmacol —2012. — Vol. 680 (1-3). — P. 102-107.152166. Panduru, M. Type 1 diabetes mellitus and atopic dermatitis - systematic reviewand meta-analysis / M. Panduru, N.M.
Panduru, D.A. Ion // Romanian Journal ofDiabetes Nutrition & Metabolic Diseases. — 2012. — Vol. 19 (2). — P. 201-205.167. Petrovsky, N. The role of Fas ligand in beta cell destruction in autoimmunediabetes of NOD mice / N. Petrovsky, D. Silva, L. Socha, R. Slattery, B. Charlton //Ann N Y Acad Sci. — 2002. — Vol. 958 (1).
— P. 204-208.168. Pfaundler, M. Über Syntropie von Krankheitszuständen / M. Pfaundler, L. vonSeht // Zeitschrift Für Kinderheilkunde. — 1921. — Vol. 30. — P. 298-313.169. Popov, D. Is lung a target of diabetic injury? The novel pro and cons evidences /D. Popov // Proc. Rom. Acad., Series B. — 2013. — Vol. 15 (2). — P. 99-104.170. Puzyrev, V.P. Syntropy, genetics testing and personalized medicine / V.P.Puzyrev, O.A.
Makeeva, M.B. Freidin // Person. Med. — 2010. — V. 4 (7). — P. 399405.171. Rabin, R.L. The nexus between atopic disease and autoimmunity: a review of theepidemiological and mechanistic literature / R.L. Rabin, A.I. Levinson // Clin ExpImmunol. — 2008. — Vol. 153 (1). — P. 19-30.172.
Rachmiel, M. Clinical characteristics and diabetes associated autoantibodies inpatients with both type 1 diabetes mellitus and asthma / M. Rachmiel, O. Bloch, T.Bistritzer, N. Weintrob, R. Ofan, Κ. Bloch,P. Vardi, M.J. Rapoport // J PediatrEndocrinol Metab.
— 2006. — Vol. 19 (8). — P. 1001-1006.173. Rachmiel, M. TH1/TH2 cytokine balance in patients with both type 1 diabetesmellitus and asthma / M. Rachmiel, O. Bloch, T. Bistritzer, N. Weintrob, R. Ofan, N.Koren-Morag, M.J. Rapoport // Cytokine. — 2006 — Vol. 34 (3-4). — P. 170-176.174.
Rachmiel, M. Young patients with both type 1 diabetes mellitus and asthma havea unique IL-12 and IL-18 secretory pattern / M. Rachmiel, O. Bloch, A.A. Shaul, G.Ben-Yehudah, Z. Bistritzer, N. Weintrob, R. Ofan, M.J. Rapoport // Pediatr Diabetes.— 2011. — Vol. 12 (7). — P. 596-603.175. Rajala, M.W. Adipose-derived resistin and gut-derived resistin-like moleculebeta selectively impair insulin action on glucose production / M.W.
Rajala, S. Obici,P.E. Scherer, L. Rossetti // J Clin Invest. — 2003. — Vol. 111 (2). — P. 225-230.153176. Rogala, B. Do the molecules CD26 and lymphocytes activation gene-3differentiate between type 1 and 2 T cell responses / B. Rogala, J. Gluck, B. Mazur // JInvestig Allergol Clin Immunol. — 2002. — Vol. 12 (3). — P. 198-203.177.
Rosenbauer, J. Atopic eczema in early childhood could be protective against type1 diabetes / J. Rosenbauer, P. Herzig, G. Giani // Diabetologia. — 2003. — Vol. 46 (6).— P. 784-788.178. Saleh, N.M. Genetic association analyses of atopic illness and proinflammatorycytokine genes with type 1 diabetes // N.M. Saleh, S.M. Raj, D.J. Smyth, C. Wallace,J.M.
Howson, L. Bell, N.M. Walker, H.E. Stevens, J.A. Todd // Diabetes Metab ResRev. — 2011. — Vol. 27 (8). — P. 838-843.179. Sankarasubbu, U. A study on the duration of diabetes and changes in lungfunction in type 1 diabetes mellitus / U. Sankarasubbu, B. Kabali // WJMS. — 2013. —Vol. 8 (2). — P.
147-149.180. Sarkar, A. α-Melanocyte-stimulating hormone induces cell death in mast cells:involvement of NF-kappaB / A. Sarkar, Y. Sreenivasan, S.K. Manna // FEBS Lett. —2003. — Vol. 549 (1-3). — P. 87-93.181. Sebastiani, L. Type 1 diabetes in Lazio: note 2- case control study of risk factors /L. Sebastiani, N. Visalli, E. Adorisio, R. D'Elia, A. Conte, P. Pozzilli // Ann Ig.
—2001. — Vol. 13 (6). — P. 523-530.182. Sharara-Chami, R.I. Epinephrine deficiency results in intact glucose counterregulation, severe hepatic steatosis and possible defective autophagy in fasting mice /R.I. Sharara-Chami, Y. Zhou, S. Ebert, K. Pacak, U. Ozcan, J.A. Majzoub // Int JBiochem Cell Biol. — 2012. — Vol. 44 (6). — P. 905-913.183.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
